Expression of fatty acid-CoA ligase 4 during development and in brain
- PMID: 10675551
- DOI: 10.1016/s0014-5793(00)01159-5
Expression of fatty acid-CoA ligase 4 during development and in brain
Abstract
Fatty acid utilization is initiated by fatty acid-CoA ligase, which converts free fatty acids into fatty acyl-CoA esters. We have cloned previously the human long-chain fatty acid-CoA ligase 4 (FACL4), which is a central enzyme in controlling the free arachidonic acid level in cells and thereby regulating eicosanoid production. We report here the expression of this gene in tissues, particularly in different parts of the brain. We found that FACL4 encoded a 75 kDa enzyme and that there was a modified translation product expressed in the brain. FACL4 was expressed in early stages of development with a significant amount of FACL4 mRNA detected in an E7 mouse embryo. In addition, FACL4 was highly expressed in both adult and newborn mouse brain especially in the granule cells of the dentate gyrus and the pyramidal cell layer of CA1 in hippocampus, and the granular cell layer and Purkinje cells of the cerebellum.
Similar articles
-
Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma.Cancer Res. 2001 Dec 1;61(23):8429-34. Cancer Res. 2001. PMID: 11731423
-
Fatty acid-CoA ligase 4 is overexpressed in human hepatocellular carcinoma.Cancer Sci. 2003 May;94(5):421-4. doi: 10.1111/j.1349-7006.2003.tb01458.x. Cancer Sci. 2003. PMID: 12824887 Free PMC article.
-
Cloning, expression, and chromosomal localization of human long-chain fatty acid-CoA ligase 4 (FACL4).Genomics. 1998 Apr 15;49(2):327-30. doi: 10.1006/geno.1998.5268. Genomics. 1998. PMID: 9598324
-
A third MRX family (MRX68) is the result of mutation in the long chain fatty acid-CoA ligase 4 (FACL4) gene: proposal of a rapid enzymatic assay for screening mentally retarded patients.J Med Genet. 2003 Jan;40(1):11-7. doi: 10.1136/jmg.40.1.11. J Med Genet. 2003. PMID: 12525535 Free PMC article.
-
Origins and fates of fatty acyl-CoA esters.Biochim Biophys Acta. 1992 Mar 4;1124(2):101-11. doi: 10.1016/0005-2760(92)90085-a. Biochim Biophys Acta. 1992. PMID: 1347457 Review. No abstract available.
Cited by
-
Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4.Bipolar Disord. 2014 Dec;16(8):875-80. doi: 10.1111/bdi.12220. Epub 2014 Jul 8. Bipolar Disord. 2014. PMID: 25041123 Free PMC article.
-
Liver-specific knockdown of long-chain acyl-CoA synthetase 4 reveals its key role in VLDL-TG metabolism and phospholipid synthesis in mice fed a high-fat diet.Am J Physiol Endocrinol Metab. 2019 May 1;316(5):E880-E894. doi: 10.1152/ajpendo.00503.2018. Epub 2019 Feb 5. Am J Physiol Endocrinol Metab. 2019. PMID: 30721098 Free PMC article.
-
Melanocyte expression of survivin promotes development and metastasis of UV-induced melanoma in HGF-transgenic mice.Cancer Res. 2007 Jun 1;67(11):5172-8. doi: 10.1158/0008-5472.CAN-06-3669. Cancer Res. 2007. PMID: 17545596 Free PMC article.
-
The ACSL4 Network Regulates Cell Death and Autophagy in Diseases.Biology (Basel). 2023 Jun 15;12(6):864. doi: 10.3390/biology12060864. Biology (Basel). 2023. PMID: 37372148 Free PMC article. Review.
-
Acyl-CoA synthesis, lipid metabolism and lipotoxicity.Biochim Biophys Acta. 2010 Mar;1801(3):246-51. doi: 10.1016/j.bbalip.2009.09.024. Epub 2009 Oct 8. Biochim Biophys Acta. 2010. PMID: 19818872 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous